Top stories in hematology/oncology: Evaluating postmenopausal bleeding for endometrial cancer purposes, identifying women at increased risk for triple-negative breast cancer

Among the top stories in hematology and oncology is a report that found early detection strategies that focused on women with postmenopausal bleeding could detect as many as 90% of endometrial cancers.

Other top stories include multigene hereditary cancer panel testing can identify women at increased risk for triple-negative breast cancer based on multiple mutations, the FDA expanding indications to a device so it can be used for localization of soft tissue and more. - by Jake Scott

FDA expands indication of SAVI SCOUT reflector to include localization of soft tissue

The FDA granted 510(k) clearance to Cianna Medical Inc. to extend the indication of its SAVI SCOUT reflector for use in localization of soft tissue, including lymph nodes. Read more.

Evaluation of postmenopausal bleeding can lead to early detection of endometrial cancer.

Early detection strategies that focus on women with postmenopausal bleeding could catch as many as 90% of endometrial cancers, according to findings published in JAMA Internal Medicine. Read more.

Researchers identify pathogenic variants linked to triple negative breast cancer risk

Multigene hereditary cancer panel testing can identify women at increased risk for triple-negative breast cancer based on mutations in BARD1, BRCA1, BRCA2, PALB2 and RAD51D, according to study findings. Read more.

Compression hosiery preferred option for acute deep vein thrombosis

Compression hosiery improved quality of life and appeared cost-effective for the acute phase between diagnosis of deep vein thrombosis and application of elastic compression stockings, according to results of a substudy of the IDEAL DVT study. Read more.

Fox Chase Cancer Center appoints assistant professor

Kristen Whitaker, MD, has been appointed assistant professor in the department of clinical genetics at Fox Chase Cancer Center. Read more.